EPISODE · Nov 30, 2023 · 12 MIN
November 2023 Medical News Summary
from JAMA Medical News
Why Physicians Don't Deprescribe Medicines; What to Know About Wegovy's Rare but Serious Adverse Effects; What to Know About Zepbound, the Newest Antiobesity Drug Related Content: As Semaglutide's Popularity Soars, Rare but Serious Adverse Effects Are Emerging FDA Green-Lights Tirzepatide, Marketed as Zepbound, for Chronic Weight Management Deciding When It's Better to Deprescribe Medicines Than to Continue Them
Embed this episode
NOW PLAYING
November 2023 Medical News Summary
0:00
12:18
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of JAMA Medical News?
This episode is 12 minutes long.
When was this JAMA Medical News episode published?
This episode was published on November 30, 2023.
Can I download this JAMA Medical News episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!